Invention Grant
- Patent Title: Method for producing naïve pluripotent stem cells
-
Application No.: US15558473Application Date: 2016-03-17
-
Publication No.: US10738280B2Publication Date: 2020-08-11
- Inventor: Hideyuki Okano , Seiji Shiozawa , Fumihiko Kisa
- Applicant: ONO PHARMACEUTICAL CO., LTD. , KEIO UNIVERSITY
- Applicant Address: JP Osaka JP Tokyo
- Assignee: ONO PHARMACEUTICAL CO., LTD.,KEIO UNIVERSITY
- Current Assignee: ONO PHARMACEUTICAL CO., LTD.,KEIO UNIVERSITY
- Current Assignee Address: JP Osaka JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@250dcb1d
- International Application: PCT/JP2016/058577 WO 20160317
- International Announcement: WO2016/148253 WO 20160922
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/02 ; C12N5/074 ; C12N5/10 ; C12N15/09

Abstract:
To produce and/or maintain naïve pluripotent stem cells capable of highly expressing genes important for maintaining an undifferentiated state, which could not be achieved by known methods for producing pluripotent stem cells. The present invention can produce naïve pluripotent stem cells capable of maintaining an undifferentiated state by introducing and allowing transient expression of six genes (Oct3/4, Klf4, c-Myc, Sox2, Nanog, and Klf2) among the so-called initializing factors, and further performing culturing in a medium containing LIF, an MEK inhibitor, a GSK3 inhibitor, a cAMP production promoter, a TGF-β inhibitor and a PKC inhibitor. Thus, the problem of the present invention can be solved.
Public/Granted literature
- US20180080009A1 METHOD FOR PRODUCING NAÏVE PLURIPOTENT STEM CELLS Public/Granted day:2018-03-22
Information query